IM19

· Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IM19, covering 2018-07-16 to 2018-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients [Phase 1]